by Tim Bredrup
eCardio Diagnostics, a remote cardiac arrhythmia monitoring provider, recently announced the acceptance for publication of the manuscript titled, “The Use of Mobile Cardiac Telemetry to Improve Diagnostic Accuracy and Enable More Efficient Patient Care.”
The article appears in the Arrhythmia Section of US Cardiology journal’s February issue and is currently available online.
The manuscript’s lead author, Steven Zweibel, MD, FACC, FHRS, wrote that even though mobile cardiac telemetry is a relatively new technology (first approved by the US Food and Drug Administration in 2002), the use of it has been proven to provide superior diagnostic capability for patients with palpitations, syncope, and pre-syncope because it allows for detection of both symptomatic and asymptomatic arrhythmias, including atrial fibrillation.
From the announcement:
The article references a specific patient case study of a 56-year-old male with a history of palpitations with documented runs of both supraventricular tachycardia and AFib. Because the MCT monitor provides specific documentation on the initiation and termination of arrhythmias, Dr. Zweibel received the clinical detail he needed for diagnosing the patient, and he was able to determine that invasive procedures or medication trials would be unnecessary.